A Practical Approach, Second Edition=Ronald D. Ho.pdf

322 DEVELOPMENTAL REPRODUCTIVE TOXICOLOGY: A PRACTICAL APPROACH, SECOND EDITION46. U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Pediatric ExclusivityLabeling Changes as of May 7, 2004. Accessed May 12, 2004 at http://www.fda.gov/cder/pediatric/labelchange.htm.47. Drug companies are developing nearly 200 medicines for children, in New Medicines in Developmentfor Children, The Pharmaceutical Research and Manufacturers of America (PhRMA), May 29, 2002.Accessed April 20, 2004 at http://www.phrma.org/newmedicines/resources/2002-05-29.57.pdf.48. ICH Expert Working Group, ICH Harmonised Tripartite Guideline, Maintenance of the ICH Guidelineon Non-Clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals, M3(M),International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticalsfor Human Use (ICH), Geneva, Switzerland, Finalized July, 1997.49. American Academy of Pediatrics Committee on Drugs, Guidelines for the ethical conduct of studiesto evaluate drugs in pediatric populations, Pediatrics, 95, 286, 1995.50. Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes,G., Bracken, W., Dorato, M., Van Deun, K., Smith, P., Berger, B., and Heller, A., Concordance of thetoxicity of pharmaceuticals in humans and in animals, Regul. Toxicol. Pharmacol., 32, 56, 2000.51. U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Guidance for Industry:Nonclinical Safety Evaluation of Pediatric Drug Products, U.S. Department of Health and HumanServices, Rockville, MD, 2003 (Draft).52. U.S. Environmental Protection Agency, Toxicology data requirements for assessing risks of pesticideexposure to children’s health: Report of the Toxicology Working Group of the 10X Task Force, April28, 1999 (Draft). Accessed October 13, 2004 http://www.epa.gov/scipoly/sap/1999/may/10xtx428.pdf.53. Schettler, T., Stein, J., Reich, F., Valenti, M., and Wallinga, D., In Harm’s Way: Toxic Threats to ChildDevelopment, Greater Boston Physicians for Social Responsibility (GBPSR), Cambridge, MA, 2000.Accessed October 29, 2004 at http://psr.igc.org/ihwrept/ihwcomplete.pdf.54. U.S. Environmental Protection Agency, Health Effects Test Guidelines: Prenatal Developmental ToxicityStudy, Office of Prevention, Pesticides and Toxic Substances (OPPTS), 870.3700, 1998.55. U.S. Environmental Protection Agency, Health Effects Test Guidelines: Reproduction and FertilityEffects, Office of Prevention, Pesticides and Toxic Substances (OPPTS), 870.3800, 1998.56. U.S. Environmental Protection Agency, Health Effects Test Guidelines: Developmental NeurotoxicityStudy, Office of Prevention, Pesticides and Toxic Substances (OPPTS), 870.6300, August 1998.57. Kimmel, C.A. and Makris, S.L., Recent developments in regulatory requirements for developmentaltoxicology, Toxicol. Letters, 120, 73, 2001.58. Agunod, M., Yamaguchi, N., Lopez, R., Luhby, A.L., and Glass, G.B., Correlative study of hydrochloricacid, pepsin and intrinsic factor secretion in newborns and infants, Am. J. Digest. Dis., 14,400, 1969.59. Rødbro, P., Krasilnikoff, P.A., and Christiansen, P.M., Parietal cell secretory function in early childhood,Scand. J. Gastroenterol., 2, 209, 1967.60. Huang, N.N. and High, R.H., Comparison of serum levels following the administration of oral andparenteral preparations of penicillin to infants and children of various age groups, J. Pediatr., 42, 657,1953.61. Morselli, P.L., Antiepileptic drugs, in Drug Disposition during Development, Morselli, P.L., Ed.,Spectrum, New York, 1977, p. 60.62. Siber, G.R., Echeverria, P., Smith, A.L., Paisley, J.W., and Smith, D.H., Pharmacokinetics of gentamicinin children and adults, J. Infect. Dis., 132, 637, 1975.63. Miyawaki, T., Moriya, N., Nagaoki, T., and Taniguchi, N., Maturation of B-cell differentiation abilityand T-cell regulatory function in infancy and childhood, Immunol. Rev., 57, 61, 1981.64. Barnett, J.B., Developmental immunotoxicology, in Experimental Immunotoxicology, Smialowicz,R.J. and Holsapple, M.P., Eds., CRC Press, Boca Raton, FL, 1996, p. 47.65. Holliday, S.D. and Smialowicz, R.J., Development of the murine and human immune system: differentialeffects of immunotoxicants depend on time of exposure, Environ. Health Perspect., 108, 463,2000.66. Dietert, R.R., Etzel, R.A., Chen, D., Halonen, M., Holladay, S.D., Jarabek, A.M., Landreth, K., Peden,D.B., Pinkerton, K., Smialowicz, R.J., and Zoetis, T., Workshop to identify critical windows ofexposure for children’s health: immune and respiratory systems work group summary, Environ. HealthPerspect., 108, 483, 2000.© 2006 by Taylor & Francis Group, LLC